title: [Secondary candidal infection in patients with chronic dermatoses].
abstract: Clinical and laboratory examinations of 250 patients with chronic dermatoses (eczema, neurodermatitis, psoriasis, pemphigus, etc.) have revealed secondary candidal involvement of the skin and mucosa in 121 (46.6%). C. albicans, often associated with bacillary (33.3%) or bacterial (7.3%) microflora, predominated among the yeast-like fungi isolated from the patients. These data point to the necessity of prescribing, besides the antimycotic agents, a complex of pathogenetic therapy including immunomodulators, in order to cut down the terms of treatment and prevent secondary candidal infection in the patients with chronic dermatoses.
authors.forename: S I
authors.initials: SI
authors.lastname: Dovzhanskiĭ
authors.forename: V F
authors.initials: VF
authors.lastname: Orkin
authors.forename: A K
authors.initials: AK
authors.lastname: Myshkina
authors.forename: L B
authors.initials: LB
authors.lastname: Pavlenko
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000917:Antibody Formation / Q000276:immunology; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification; D002177:Candidiasis / Q000209:etiology*; D002178:Candidiasis, Chronic Mucocutaneous / Q000209:etiology* / Q000276:immunology / Q000382:microbiology; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D012871:Skin Diseases / Q000150:complications* / Q000276:immunology / Q000382:microbiology
vernacular_title: Vtorichnaia kandidoznaia infektsiia u bol'nykh khronicheskimi dermatozami.